The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

Datafluct, a Japan-based data science platform to solve corporate and social challenges, completed a ¥1.1bn ($8.8m) series B round led by University of Tokyo Edge Capital Partners, a venture capital affiliate of the institution, today. The round also included food and drink wholesaler Kokubu, general contractor Takenaka, conglomerate Toshiba’s software services arm Toshiba Digital Solutions, insurer Mitsui Sumitomo Insurance’s investment unit Mitsui Sumitomo Insurance Capital, cosmetics producer Pola Orbis and diversified conglomerate Tokyo Boeki. Datafluct had raised $2.8m in series A funding from University of Tokyo Edge Capital Partners in April 2021.

Osmol Therapeutics, a US-based biopharmaceutical company developing a treatment to prevent chemotherapy-induced peripheral neuropathy, raised an initial $5.2m series A-1 tranche led by Koax Investment Partners yesterday. The company is targeting a $7.5m close for the round. Osmol’s lead asset is based on research at Yale University.

Sampling Human, a Czech Republic-based microorganisms-powered live diagnostics technology spinout of…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).